Opus Genetics, Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

1.880

+0.030 (1.62%)

At close: Nov 14, 2025, 4:00 PM EST

1.850

-0.030 (-1.60%)

After-hours: Nov 14, 2025, 6:23 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2001 - 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '10 Dec 31, 2010	2001 - 2009
Vision Performance and Health	10.99M	Log In	Log In	Log In	Log In	Upgrade
Vision Performance and Health Growth	-42.30%	Log In	Log In	Log In	Log In	Upgrade
Innovative Treatments	-	Log In	Log In	Log In	Log In	Upgrade
Innovative Treatments Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2001 - 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '10 Dec 31, 2010	2001 - 2009
United States	10.99M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-42.30%	Log In	Log In	Log In	Log In	Upgrade